Tandem Diabetes Care (TNDM) Free Cash Flow (QoQ) (2013 - 2026)
Powered by 
Analysis
Tandem Diabetes Care (TNDM) Free Cash Flow (QoQ) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.78 Bn | 175.17 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.04 Bn | 121.82 Bn | 1.96 Bn |
| 3 | Medtronic | 117.04 Bn | 108.22 Bn | 6.34 Bn |
| 4 | Stryker | 103.86 Bn | 100.38 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.50 Bn | 62.96 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn |
| 8 | Dexcom | 32.12 Bn | 30.17 Bn | 830.00 Mn |
| 9 | Steris | 20.69 Bn | 20.21 Bn | 684.20 Mn |
| 10 | Tandem Diabetes Care | 1.27 Bn | 811.05 Mn | 144.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,570.31% |
| Mar 31, 2026 | -18.40% |
| Dec 31, 2025 | -25.60% |
| Sep 30, 2025 | 128.83% |
| Jun 30, 2025 | 35.60% |
| Mar 31, 2025 | -393.84% |
| Dec 31, 2024 | -64.49% |
| Sep 30, 2024 | 283.46% |
| Jun 30, 2024 | 5.72% |
| Mar 31, 2024 | -0.31% |
| Dec 31, 2023 | -132.27% |
| Sep 30, 2023 | 60.99% |
| Jun 30, 2023 | 49.55% |
| Mar 31, 2023 | -14,169.43% |
| Dec 31, 2022 | -98.11% |
| Sep 30, 2022 | 296.18% |
| Jun 30, 2022 | -146.75% |
| Mar 31, 2022 | -19.67% |
| Dec 31, 2021 | -55.27% |
| Sep 30, 2021 | 14.66% |